3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
2
Sepsis
1
Neutropenia
1
Gram-Negative Bacterial Infections
1
Colorectal Neoplasms
1
Anastomotic Leak
1
Interventions
Anti-Bacterial Agents
2
ziprasidone
1
telavancin
1
soybean oil, phospholipid emulsion
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
Sevelamer
1
Saline Solution
1
Rocuronium
1
Povidone-Iodine
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Multiplex Polymerase Chain Reaction
1
Molindone
1
Methylprednisolone
1
Methods
1
Meropenem
1
Massage
1
Lurasidone Hydrochloride
1
Levofloxacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Sepsis
×
Colistin
×
Clear all
NCT01931592
2017-05-08
CLEAR
University of Cologne
Phase 2/3
Terminated
29 enrolled